stockrow
Friday 6 November 2026
Export LFMD’s income statement to Excel — free account
LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024.
- Revenue
- −3.55%
- EPS
- −166.7%
- Free cash flow
- −247.5%
Quarter to June 2026, against a year earlier
2.36
0.07
+3.06%
Follow LFMD
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 5 | 4 | 8 | 12 | 37 | 93 | 119 | 153 | 155 | 194 | 192 | +49.4% | 208 | 245 | 282 | +13.3% | |
| Gross margin, % | 62.85 | 72.36 | 76.02 | 79.75 | 76.24 | 80.62 | 84.32 | 87.61 | 86.15 | 85.72 | 87.50 | +22.9 pt | ||||||
| EBT | (1) | (1) | (2) | (4) | (60) | (61) | (45) | (17) | (23) | (10) | (21) | +26.6% | ||||||
| EBT margin, % | (23.35) | (37.46) | (28.96) | (29.28) | (161.96) | (66.02) | (37.52) | (11.41) | (14.58) | (5.25) | (11.22) | +18.1 pt | ||||||
| Net income | (1) | (1) | (1) | (4) | (61) | (61) | (45) | (18) | (21) | 16 | 0 | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 0.78 | 0.44 | 0.94 | 1.26 | 2.61 | 3.44 | 3.84 | 4.50 | 3.76 | 4.30 | 4.01 | +20.8% | |||||
| Earnings | (0.17) | (0.15) | (0.10) | (0.35) | (4.44) | (2.29) | (1.57) | (0.70) | (0.60) | 0.25 | (0.05) | n/m | ||||||
| Cash flow | (0.06) | (0.10) | (0.10) | 0.03 | (0.85) | (1.22) | (0.74) | 0.26 | 0.43 | 0.18 | (0.21) | n/m | ||||||
| Capex | 0.00 | 0.00 | (0.01) | 0.00 | (0.03) | (0.13) | (0.42) | (0.26) | (0.20) | (0.21) | (0.18) | n/m | ||||||
| Free cash flow | (0.06) | (0.10) | (0.11) | 0.03 | (0.88) | (1.35) | (1.16) | 0.00 | 0.23 | (0.03) | (0.38) | (8.5%) | ||||||
| Book value | (0.05) | 0.07 | 0.09 | (0.11) | (0.06) | 0.96 | (0.24) | 0.16 | (0.18) | 0.51 | 0.17 | n/m | ||||||
| Shares, m | 7 | 8 | 9 | 10 | 14 | 27 | 31 | 34 | 41 | 45 | 47 | +23.6% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.12 | 0.00 | 1.3 | |||||
| P/S | 1.53 | 4.08 | 0.74 | 0.46 | 2.50 | 1.13 | 0.49 | 1.87 | 1.32 | 0.79 | 0.57 | 1.5 | ||||||
| P/B | 0.00 | 24.13 | 7.55 | 0.00 | 0.00 | 4.81 | 0.00 | 51.35 | 0.00 | 6.65 | 13.74 | 9.4 | ||||||
| EV/Sales | 1.52 | 4.07 | 0.73 | 0.44 | 2.28 | 0.70 | 0.49 | 1.78 | 1.22 | 0.68 | 0.52 | 1.4 | ||||||
| EV/FCF | (19.50) | (18.34) | (6.70) | 21.79 | (6.76) | (1.78) | (1.64) | 3,127.18 | 20.37 | (106.73) | (5.46) | 300.8 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | 0 | (1) | (1) | 0 | (12) | (33) | (23) | 9 | 18 | 8 | (10) | n/m | |||||
| Capex | — | — | 0 | — | 0 | (3) | (13) | (9) | (8) | (10) | (8) | +91.7% | ||||||
| Free cash flow | 0 | (1) | (1) | 0 | (13) | (36) | (36) | 0 | 9 | (1) | (18) | +13.1% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 0 | 1 | 0 | (1) | (2) | 22 | (20) | 8 | (15) | 10 | (5) | n/m | |||||
| Net debt | 0 | 0 | 0 | 0 | (8) | (39) | 0 | (15) | (14) | (37) | (25) | +96.9% | ||||||
| Shareholders’ equity | 0 | 1 | 1 | (1) | (1) | 26 | (7) | 6 | (8) | 23 | 8 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | (178.87) | (117.45) | (63.96) | (103.50) | (752.12) | (195.08) | (128.70) | (56.34) | (36.43) | 15.35 | (4.35) | +194.2 pt | |||||
| ROIC | 0.00 | (118.32) | (144.88) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 pt | ||||||
| ROE | 1,225.79 | (923.78) | (172.03) | 2,027.27 | 2,260.22 | (716.97) | (988.99) | 751.79 | 2,465.96 | 144.18 | (69.60) | (1,081.6) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 11 | 10 | 16 | 26 | 56 | 232 | 220 | 232 | 336 | 389 | — | +48.6% | |||||
| Revenue/emp, $m | 0.48 | 0.37 | 0.52 | 0.48 | 0.67 | 0.40 | 0.54 | 0.66 | 0.46 | 0.50 | — | +0.5% | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 26 Oct 2026
LifeMD, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CTEV Claritev Corporation | $342.7M | — (loss-making) | — (loss-making) | +6.59% (above 0%: growing) | n/m | +49.10% (above 0%: growing) | 73.72% | 9.09% | Compare |
| SPOK Spok Holdings, Inc. | $245.9M | 12.9× | 16.2× | −2.56% (below 0%: shrinking) | +190.31% (above 0%: growing) | +61.57% (above 0%: growing) | 79.66% | 17.08% | Compare |
| AMWL American Well Corporation | $208.5M | — (loss-making) | — (loss-making) | −12.96% (below 0%: shrinking) | n/m | +21.98% (above 0%: growing) | 52.99% | (23.79%) | Compare |
| SY So-Young International Inc. Sponsored ADR | $177.7M | — (loss-making) | 12.8× | +40.84% (above 0%: growing) | n/m | −798.37% (below 0%: shrinking) | 44.11% | (8.64%) | Compare |
| DH Definitive Healthcare Corp. | $163.7M | — (loss-making) | — (loss-making) | −8.99% (below 0%: shrinking) | n/m | −32.60% (below 0%: shrinking) | 77.27% | (9.09%) | Compare |
| OPRX OptimizeRx Corp. | $163.3M | 35.8× | 41.7× | −29.77% (below 0%: shrinking) | n/m | +89.86% (above 0%: growing) | 76.51% | (0.43%) | Compare |
| HCAT Health Catalyst, Inc. | $112.9M | — (loss-making) | — (loss-making) | −26.26% (below 0%: shrinking) | n/m | +65.58% (above 0%: growing) | 42.71% | 89.08% | Compare |
| LFMD LifeMD, Inc. | $110.4M | — (loss-making) | — (loss-making) | −3.55% (below 0%: shrinking) | n/m | −247.52% (below 0%: shrinking) | 88.82% | (15.08%) | |
| CCLD CareCloud, Inc. | $91.8M | 16.5× | 11.0× | +8.56% (above 0%: growing) | +150.00% (above 0%: growing) | −0.44% (below 0%: shrinking) | 50.46% | 19.50% | Compare |
| Median of peers | $170.7M | 16.5× | 14.5× | −5.77% | — | +35.54% | 63.36% | 4.33% |
Pay and ownership Proxy statement filed 30 April 2026
Chief executive’s pay
| Year | Total pay | Actually paid | $100 invested |
|---|---|---|---|
| 2025 | 777.08k | 777.08k | 52.22 |
| 2024 | 1.06m | 1.06m | 63.06 |
| 2023 | 888.80k | 948.30k | 105.61 |
Ownership
Directors and executive officers, together
17.22%
Justin Schreiber
5.68%
BlackRock, Inc.
5.21%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards
at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s
shares at the start of the earliest year shown was worth at each year’s end.
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement